Recovatone NDC 44911-0542

NDC codes

FDA NDC Directory

Product NDC (as listed)44911-0542Labeler and product segments. Claims need a package NDC.

Product NDC at billing width44911-0542Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
44911-0542-1	44911054201	120 mL in 1 BOTTLE, DROPPER (44911-0542-1)Marketed from May 8, 2020

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Recovatone
Generic name (nonproprietary): glycyrrhiza glabra, kali muriaticum, kali phosphoricum, iodium, zincum gluconicum, phosphorus, ascorbicum acidum, calcium gluconate, l-arginine, l-carnitine, l-ornithine, magnesia muriatica, magnesium gluconicum dihydricum, manganese gluconate, natrum muriaticum, cobalt gluconate, copper gluconate, creatine, l-glutamine, l-leucine, l-valine, potassium gluconate, selenium dioxide, adrenalinum, boron, calcarea phosphorica, ferrum sulphuricum, molybdenum, niccolum metallicum, selenium metallicum,
Active ingredients: Glycyrrhiza glabra — 1 [hp_X]/mLPotassium chloride — 2 [hp_X]/mLDibasic potassium phosphate — 3 [hp_X]/mLIodine — 4 [hp_X]/mLZinc gluconate — 4 [hp_X]/mLPhosphorus — 5 [hp_X]/mLAscorbic acid — 6 [hp_X]/mLCalcium gluconate — 6 [hp_X]/mLArginine — 6 [hp_X]/mLCarnitine — 6 [hp_X]/mLOrnithine — 6 [hp_X]/mLMagnesium chloride — 6 [hp_X]/mLMagnesium gluconate — 6 [hp_X]/mLManganese gluconate — 6 [hp_X]/mLSodium chloride — 6 [hp_X]/mLCobaltous gluconate — 8 [hp_X]/mLCopper gluconate — 8 [hp_X]/mLCreatine — 8 [hp_X]/mLGlutamine — 8 [hp_X]/mLLeucine — 8 [hp_X]/mLValine — 8 [hp_X]/mLPotassium gluconate — 8 [hp_X]/mLSelenium dioxide — 8 [hp_X]/mLEpinephrine — 10 [hp_X]/mLBoron — 12 [hp_X]/mLTribasic calcium phosphate — 12 [hp_X]/mLFerrous sulfate — 12 [hp_X]/mLMolybdenum — 12 [hp_X]/mLNickel — 12 [hp_X]/mLSelenium — 12 [hp_X]/mLStrontium carbonate — 12 [hp_X]/mLVanadium — 12 [hp_X]/mLChromium — 14 [hp_X]/mLCorticotropin — 15 [hp_C]/mL
Dosage form: Liquid
Route: Oral
Labeler: Energique, Inc.
Product type: Over-the-counter drug
Marketing category: Unapproved homeopathic
Marketing start: May 8, 2020
Marketing end: Jul 11, 2027
Other FDA classes: Adrenergic alpha-Agonists (Mechanism)Adrenergic beta-Agonists (Mechanism)Adrenocorticotropic Hormone (Chemical structure)Allergens (Chemical structure)Allergens (Chemical structure)Allergens (Chemical structure)Amino Acids (Chemical structure)Ascorbic Acid (Chemical structure)Calcium (Chemical structure)Calcium (Chemical structure)Catecholamines (Chemical structure)Divalent (Chemical structure)Divalent (Chemical structure)Cell-mediated Immunity (Physiologic effect)Cell-mediated Immunity (Physiologic effect)Cell-mediated Immunity (Physiologic effect)Decreased Copper Ion Absorption (Physiologic effect)Dietary Proteins (Chemical structure)Increased Coagulation Factor Activity (Physiologic effect)Increased Coagulation Factor Activity (Physiologic effect)Increased Histamine Release (Physiologic effect)Increased Histamine Release (Physiologic effect)Increased Histamine Release (Physiologic effect)Increased Large Intestinal Motility (Physiologic effect)Increased Large Intestinal Motility (Physiologic effect)Increased Large Intestinal Motility (Physiologic effect)Increased Large Intestinal Motility (Physiologic effect)Inhibition Large Intestine Fluid/Electrolyte Absorption (Physiologic effect)Inhibition Large Intestine Fluid/Electrolyte Absorption (Physiologic effect)Inhibition Large Intestine Fluid/Electrolyte Absorption (Physiologic effect)Inhibition Large Intestine Fluid/Electrolyte Absorption (Physiologic effect)Inhibition Small Intestine Fluid/Electrolyte Absorption (Physiologic effect)Inhibition Small Intestine Fluid/Electrolyte Absorption (Physiologic effect)Magnesium Ion Exchange Activity (Mechanism)Magnesium Ion Exchange Activity (Mechanism)Magnetic Resonance Contrast Activity (Mechanism)Osmotic Activity (Mechanism)Osmotic Activity (Mechanism)Osmotic Activity (Mechanism)Osmotic Activity (Mechanism)Phosphate Chelating Activity (Mechanism)Phosphate Chelating Activity (Mechanism)Plant Proteins (Chemical structure)Potassium Compounds (Chemical structure)Potassium Compounds (Chemical structure)Stimulation Large Intestine Fluid/Electrolyte Secretion (Physiologic effect)Stimulation Large Intestine Fluid/Electrolyte Secretion (Physiologic effect)
Identifiers: Product ID 44911-0542_7c195150-c710-4d62-9d80-d1bdecd99e6aSPL ID 7c195150-c710-4d62-9d80-d1bdecd99e6aSPL set ID 38fd4f98-a42a-435b-9643-16df66453951UNII 2788Z9758H, 660YQ98I10, CI71S98N1Z, 9679TC07X4, U6WSN5SQ1Z, 27YLU75U4W, PQ6CK8PD0R, SQE6VB453K, 94ZLA3W45F, S7UI8SM58A, E524N2IXA3, 02F3473H9O, T42NAD2KHC, 9YY2F980SV, 451W47IQ8X, 26SK597UWV, RV823G6G67, MU72812GK0, 0RH81L854J, GMW67QNF9C, HG18B9YRS7, 12H3K5QKN9, 9N3UK29E57, YKH834O4BH, N9E3X5056Q, 91D9GV0Z28, 39R4TAN1VT, 81AH48963U, 7OV03QG267, H6241UJ22B, 41YPU4MMCA, 00J9J9XKDE, 0R0008Q3JB, K0U68Q2TXA
Pharmacologic class: Adrenocorticotropic Hormone; Amino Acid; Blood Coagulation Factor; Calculi Dissolution Agent; Catecholamine; Copper Absorption Inhibitor; Non-Standardized Food Allergenic Extract; Non-Standardized Plant Allergenic Extract; Osmotic Laxative; Paramagnetic Contrast Agent; Phosphate Binder; Potassium Salt; Standardized Chemical Allergen; Vitamin C; alpha-Adrenergic Agonist; beta-Adrenergic Agonist

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N444911054201 followed by a unit qualifier and the quantity

Package 44911-0542-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Oct 29, 2024.

Indications (excerpt from the label)

INDICATIONS: May temporarily relieve symptoms associated with exertions, such as muscle pain, muscle weakness, trembling of limbs, and cramps.** **Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)